Locations in India
Our API sites in India
We have two sites in India, in Vizag (Andhra Pradesh region) and in Chennai (Tamil Nadu region) dedicated to development and manufacturing services for small-molecule generic APIs, amino acids, and intermediates.
Vizag site
- PharmaZell plant
- Process development, pilot, and large-scale commercial production
- Generic APIs and CDMO services
- cGMP kilo laboratory
Located in Vizag (South India, Andhra Pradesh), this site was established in 2007. This state-of-the-art facility with 62,700 sqm space is dedicated to developing and manufacturing services for small-molecule generic APIs. A team of over 250 employees produces a range of commercial APIs for specific therapeutic areas such as anti-inflammatory, anti-hypertensive, diuretic, and multiple sclerosis. The site also supports our global CDMO services.
Most recent inspections:
- Indian Health Authority 2022
- FDA (US), regular, 2021
- WHO GMP 2021
- CDSCO (IN), regular, 2018
- PMDA (JP), 2018
- Government of Upper Bavaria, competent authority (Germany), regularly, 2017
- KFDA (Korea), 2011
Chennai site
- PharmaZell plant
- Small molecule APIs, Amino Acids and intermediates
- Electrochemical reactions and hydrogenations
Located in Chennai (India’s east coast), this site was founded in 1994 to scale up and manufacture small molecule APIs, amino acids, and intermediates. With a qualified team of more than 200 employees, the site offers broad expertise in technologies such as electrochemical reactions and hydrogenation. More than 1,500 tons of small molecule APIs are produced each year.
Most recent inspections:
- Anvisa (BRA) 2023
- WHO GMP 2023
- PMDA (JP), 2023
- CDSCO (IN), regular, 2019
- FDA (US), regular, 2017
- Government of Upper Bavaria, competent authority (Germany), regularly, 2017
- KFDA (Korea), 2011
- Audits for certification, surveillance, and recertification of QMS, EMS, and HACCP
- Regular customer audits
